Inhibition of nNOS and COX-2 expression by lutein in acute retinal ischemia

Nutrition

Volumn 22, Issue 6, 2006, Pages 668-671

  Choi, Jun Sub ^a   Kim, Dongmyung ^a   Hong, Yeon Mi ^a   Mizuno, Satoshi ^b   Joo, Choun Ki ^a  

^a The Catholic University of Korea   (South Korea)

^b Kemin Industries Inc   (United States)

Author keywords

Cyclo oxygenase 2; Ischemia; Lutein; Neuronal nitric oxide synthase; Retina

Indexed keywords

ANTIOXIDANT; CAROTENOID; CYCLOOXYGENASE 2; FLORAGLO; NEURONAL NITRIC OXIDE SYNTHASE; XANTHOPHYLL;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; ENZYME ASSAY; ENZYME LOCALIZATION; ENZYME REGULATION; INHIBITION KINETICS; INTRAOCULAR HYPERTENSION; MICROSCOPY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RETINA CELL; RETINA DEGENERATION; RETINA ISCHEMIA; TISSUE DISTRIBUTION; TISSUE LEVEL; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE; INJECTIONS, INTRAPERITONEAL; ISCHEMIA; LUTEIN; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RETINA; VITREOUS BODY;

ANIMALIA;

EID: 33646408158     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2005.08.011     Document Type: Article

References (24)

1. Junghans A., Sies H., and Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 391 (2001) 160-164
2. Khachik F., Bernstein P.S., and Garland D.L. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38 (1997) 1802-1811
3. Sies H., and Stahl W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62 (1995) S1315-S1321
4. Sujak A., Gabrielska J., Grudzinski W., Borc R., Mazurek P., and Gruszecki W.I. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage. the structural aspects. Arch Biochem Biophys 371 (1999) 301-307
5. Krinsky N.I., Landrum J.T., and Bone R.A. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23 (2003) 171-201
6. Landrum J.T., Bone R.A., Joa H., Kilburn M.D., Moore L.L., and Sprague K.E. A one year study of the macular pigment. the effect of 140 days of a lutein supplement. Exp Eye Res 65 (1997) 57-62
7. Mozaffarieh M., Sacu S., and Wedrich A. The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration. a review based on controversial evidence. Nutr J 2 (2003) 20
8. Polidori M.C., Cherubini A., Stahl W., Senin U., Sies H., and Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients. relationship to early outcome. Free Radic Res 36 (2002) 265-268
9. Facchinetti F., Dawson V.L., and Dawson T.M. Free radicals as mediators of neuronal injury. Cell Mol Neurobiol 18 (1998) 667-682
10. Goldblum D., and Mittag T. Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vis Res 42 (2002) 471-478
11. Osborne N.N., Casson R.J., Wood J.P., Chidlow G., Graham M., and Melena J. Retinal ischemia. mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23 (2004) 91-147
12. Almli L.M., Hamrick S.E., Koshy A.A., Tauber M.G., and Ferriero D.M. Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons. Brain Res Dev Brain Res 132 (2001) 121-129
13. Moro M.A., Cardenas A., Hurtado O., Leza J.C., and Lizasoain I. Role of nitric oxide after brain ischaemia. Cell Calcium 36 (2004) 265-275
14. Goldstein I.M., Ostwald P., and Roth S. Nitric oxide. a review of its role in retinal function and disease. Vis Res 36 (1996) 2979-2994
15. Scorziello A., Pellegrini C., Secondo A., Sirabella R., Formisano L., Sibaud L., et al. Neuronal NOS activation during oxygen and glucose deprivation triggers cerebellar granule cell death in the later reoxygenation phase. J Neurosci Res 76 (2004) 812-821
16. Dore S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., et al. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol 54 (2003) 155-162
17. Ju W.K., Kim K.Y., and Neufeld A.H. Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp Eye Res 77 (2003) 137-145
18. Nogawa S., Zhang F., Ross M.E., and Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17 (1997) 2746-2755
19. Sairanen T., Ristimaki A., Karjalainen-Lindsberg M.L., Paetau A., Kaste M., and Lindsberg P.J. Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol 43 (1998) 738-747
20. Sasaki T., Kitagawa K., Yamagata K., Takemiya T., Tanaka S., Omura-Matsuoka E., et al. Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice. J Cereb Blood Flow Metab 24 (2004) 107-113
21. Strauss K.I., and Marini A.M. Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. J Neurotrauma 19 (2002) 627-638
22. Hewett S.J., Uliasz T.F., Vidwans A.S., and Hewett J.A. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 293 (2000) 417-425
23. Alves-Rodrigues A., and Shao A. The science behind lutein. Toxicol Lett 150 (2004) 57-83
24. Chan C., Leung I., Lam K.W., and Tso M.O. The occurrence of retinol and carotenoids in human subretinal fluid. Curr Eye Res 17 (1998) 890-895